Desentum
A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system.
Total raised
€22M
€21,900,000
Funding rounds
3
Investors
2
distinct backers
Active since
2018-09
latest 2024-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood24
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 15y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-02-20 | Other | €12M | Springvest Oy | View deal → |
| 2022-01-21 | Other | €8.0M | Springvest Oy | View deal → |
| 2018-10-01 | Grant | €1.9M | EU | View deal → |
Investors
2Related news
- Desentum Raises M€8 in Fundingfinsmes.com · 2022-01
- goodnewsfinland.com
- siliconcanals.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Nokia€859MFinland · Telecom